Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects

BACKGROUND: The first COVID-19 vaccines are being distributed to the general population. However, the shortage of doses is slowing down the goal of reaching herd immunity. The aim of the study was to verify whether previously SARS-CoV-2 infected subjects, a considerable portion of the population, sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Davide, Di Resta, Chiara, Tomaiuolo, Rossella, Sabetta, Eleonora, Pontillo, Marina, Motta, Andrea, Locatelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196312/
https://www.ncbi.nlm.nih.gov/pubmed/34147292
http://dx.doi.org/10.1016/j.vaccine.2021.06.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196312/
https://www.ncbi.nlm.nih.gov/pubmed/34147292
http://dx.doi.org/10.1016/j.vaccine.2021.06.020

Ejemplares similares